WEISS MICHAEL S
Transactions
50
Companies
10
Filings
15
CIK
0001038977
Recent Transactions
- Award
- Gift
- Gift
- Disposition from Tender
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Purchase
- Purchase
COMMON STOCK, PAR VALUE $0.001
2023-11-14$1.70/sh+147,058→ 1,130,520 total - Purchase
- Award
- Award
- Award
- Purchase
COMMON STOCK, PAR VALUE $0.001
2023-02-10$0.83/sh+1,197,604→ 14,752,034 total - Award
- Award
- Award
- Award
- Sale
- Sale
- Award
- Award
- Gift
- Gift
- Gift
- Award
- Award
- Award
- Award
- Gift
- Gift
- Gift
- Gift
- Gift
- Gift
- Gift
- Gift
- Award
- Award
- Award
- Award
- Award
- Purchase
- Award
Companies
10- $ATXI
AVENUE THERAPEUTICS, INC.
Director
Checkpoint Therapeutics, Inc.
Director
- $FBIO
Fortress Biotech, Inc.
Director
GENTA INC DE/
Director
KERYX BIOPHARMACEUTICALS INC
10% Owner
- $MBIO
MUSTANG BIO, INC.
Exec. Chairman of the Board
NATIONAL HOLDINGS CORP
10% Owner
Origo Acquisition Corp
Director, Co-Chairman of the Board
- $TGTX
TG THERAPEUTICS, INC.
Director, CEO
- $XTLB
XTL BIOPHARMACEUTICALS LTD
Director
Recent Filings
15- 4
WEISS MICHAEL S
Jan 9, 2026
- 4
WEISS MICHAEL S
Nov 7, 2025
- 4
WEISS MICHAEL S
May 30, 2025
- 4
WEISS MICHAEL S
Jan 30, 2025
- 4
WEISS MICHAEL S
Jan 3, 2025
- 4
WEISS MICHAEL S
Dec 17, 2024
- 4
WEISS MICHAEL S
May 16, 2024
- 4
WEISS MICHAEL S
Jan 8, 2024
- 4
WEISS MICHAEL S
Jan 3, 2024
- 4
WEISS MICHAEL S
Nov 16, 2023
- 4
WEISS MICHAEL S
Aug 14, 2023
- 4
WEISS MICHAEL S
Jul 7, 2023
- 4
WEISS MICHAEL S
Jun 15, 2023
- 4
WEISS MICHAEL S
Apr 3, 2023
- 4
WEISS MICHAEL S
Mar 14, 2023
Address
3020 CARRINGTON MILL BLVD, SUITE 475
MORRISVILLE, NC, 27560